Wound Healing and Tissue Regeneration

Dr. Sarah Chen
PhD, Molecular Biology
Wound healing is a complex, coordinated biological process through which the body repairs damaged tissue [1].
Definition
Wound healing is a complex, coordinated biological process through which the body repairs damaged tissue [1]. It proceeds through four overlapping phases — hemostasis, inflammation, proliferation, and remodeling — each governed by specific growth factors, cytokines, and cell populations [1][5]. PDRN was originally developed as a pharmaceutical agent to accelerate wound healing, particularly in conditions where normal repair is impaired, such as diabetic ulcers and ischemic wounds [2][3].
Phases of Wound Healing
Phase 1: Hemostasis (Minutes)
Immediately after tissue injury, platelets aggregate at the wound site, forming a fibrin clot that stops bleeding and creates a provisional matrix [1]. Platelets release growth factors (PDGF, TGF-β) that recruit immune cells and fibroblasts to the wound [1][5].
Phase 2: Inflammation (Days 1-5)
Neutrophils and macrophages infiltrate the wound to clear debris, bacteria, and damaged cells [1]. Pro-inflammatory cytokines (TNF-α, IL-1β, IL-6) coordinate the immune response [1][4]. This phase is essential but must resolve for healing to progress — chronic inflammation stalls wound repair [1][5].
PDRN's role: PDRN's A2A receptor activation modulates the inflammatory phase by suppressing NF-κB-mediated cytokine production without ablating the necessary immune response [3][4]. This helps transition the wound from inflammation to proliferation more efficiently [3].
Phase 3: Proliferation (Days 4-21)
The proliferative phase involves three concurrent processes [1][5]:
- Angiogenesis — New blood vessels grow into the wound bed, restoring oxygen and nutrient delivery. VEGF is the primary driver [1][2][5]
- Fibroplasia — Fibroblasts migrate into the wound and synthesize new extracellular matrix (collagen, hyaluronic acid, fibronectin) [1][5]
- Re-epithelialization — Keratinocytes at wound edges proliferate and migrate across the wound surface to restore the epidermal barrier [1]
PDRN's role: PDRN directly enhances all three proliferative processes. It upregulates VEGF expression for angiogenesis [2], stimulates fibroblast proliferation and collagen synthesis [3][6], and provides nucleotide building blocks through the salvage pathway for the DNA synthesis required by rapidly dividing cells [3][6].
Phase 4: Remodeling (Weeks to Months)
The final phase involves maturation of the newly formed tissue [1]. Collagen type III (produced early in healing) is gradually replaced by stronger collagen type I [1][5]. The extracellular matrix is reorganized, and excess cells undergo apoptosis [1]. This phase can continue for 12 months or longer, and the quality of remodeling determines the final appearance of the healed tissue [1].
PDRN's role: By establishing a healthier tissue foundation during the proliferative phase — more organized collagen deposition, better vascularization — PDRN promotes superior remodeling outcomes [2][3][6].
Impaired Wound Healing
Several conditions impair normal wound healing, creating a clinical need for regenerative therapies like PDRN [1][2][5]:
- Diabetes — Hyperglycemia impairs neutrophil function, reduces growth factor expression, and damages microvasculature [1][2]
- Ischemia — Reduced blood flow deprives the wound of oxygen and nutrients necessary for repair [2]
- Aging — Age-related decline in fibroblast function, growth factor production, and immune efficiency slows healing [1][5]
- Chronic inflammation — Wounds trapped in the inflammatory phase (chronic ulcers) cannot progress to proliferation [1][4]
PDRN has demonstrated efficacy in each of these impaired healing contexts. In a landmark study, PDRN significantly accelerated wound closure in genetically diabetic mice by stimulating angiogenesis and overcoming the growth factor deficiency characteristic of diabetic wounds [2].
Relevance to Aesthetic Dermatology
The same wound healing biology that makes PDRN effective for chronic ulcers also explains its aesthetic benefits [3][6]:
- Post-procedure recovery — Laser treatments, microneedling, and chemical peels create controlled wounds. PDRN accelerates the healing of these intentional injuries [3]
- Skin rejuvenation — Photoaged skin exhibits many of the same features as chronic wounds: reduced collagen, impaired vasculature, chronic low-grade inflammation [3][6]. PDRN addresses all three through the same mechanisms it uses in wound healing
- Scar prevention — By promoting organized collagen deposition and adequate angiogenesis during healing, PDRN may improve the quality of scar remodeling [2][3]
Understanding wound healing biology clarifies why PDRN's effects are progressive rather than instantaneous — the biological remodeling processes require weeks to months to produce visible changes, mirroring the natural timeline of tissue repair [1][3].
References
- [1]Gurtner GC, Werner S, Barrandon Y, Longaker MT. Wound repair and regeneration. Nature. 2008;453(7193):314-321. doi:10.1038/nature07039
- [2]Galeano M, Bitto A, Altavilla D, et al.. Polydeoxyribonucleotide stimulates angiogenesis and wound healing in the genetically diabetic mouse. Wound Repair Regen. 2008;16(2):208-217. doi:10.1111/j.1524-475X.2008.00361.x
- [3]Squadrito F, Bitto A, Irrera N, et al.. Pharmacological Activity and Clinical Use of PDRN. Curr Pharm Des. 2017;23(27):3948-3957. doi:10.2174/1381612823666170516153716
- [4]Bitto A, Polito F, Irrera N, et al.. Polydeoxyribonucleotide reduces cytokine production and the severity of collagen-induced arthritis by stimulation of adenosine A2A receptor. Arthritis Res Ther. 2011;13(1):R28. doi:10.1186/ar3254
- [5]Barrientos S, Stojadinovic O, Golinko MS, Brem H, Tomic-Canic M. Growth factors and cytokines in wound healing. Wound Repair Regen. 2008;16(5):585-601. doi:10.1111/j.1524-475X.2008.00410.x
- [6]Veronesi F, Dallari D, Sabbioni G, Carubbi C, Martini L, Fini M. Polydeoxyribonucleotides (PDRNs): From Physical Chemistry to Biological Activities and Clinical Applications. Int J Mol Sci. 2017;18(9):1927. doi:10.3390/ijms18091927